{"id":"cisplatin-based-chemotherpay","safety":{"commonSideEffects":[{"rate":"30-90%","effect":"Nausea and vomiting"},{"rate":"20-80%","effect":"Neutropenia"},{"rate":"10-50%","effect":"Anemia"},{"rate":"5-30%","effect":"Thrombocytopenia"},{"rate":"5-20%","effect":"Kidney damage"}]},"_chembl":{"chemblId":"CHEMBL197201","moleculeType":"Small molecule","molecularWeight":"520.35"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"This leads to cell death, particularly in rapidly dividing cancer cells. Cisplatin also induces apoptosis and can cause DNA damage, further contributing to its anticancer effects.","oneSentence":"Cisplatin works by crosslinking DNA, thereby inhibiting DNA replication and transcription.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T02:30:47.737Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Metastatic non-small cell lung cancer"},{"name":"Testicular cancer"},{"name":"Ovarian cancer"},{"name":"Bladder cancer"},{"name":"Stomach cancer"}]},"trialDetails":[{"nctId":"NCT01670409","phase":"PHASE2","title":"Study of Simultaneous Modulated Accelerated Radiation Therapy Concurrent With Chemotherapy to Treat Esophageal Cancer","status":"COMPLETED","sponsor":"Chuangzhen Chen","startDate":"2012-08","conditions":"Esophageal Neoplasms","enrollment":85},{"nctId":"NCT05144100","phase":"PHASE2, PHASE3","title":"Surgery Vs Chemoradiation for Oropharyngeal Cancer- A Phase II/III Integrated Design Randomized Control Trial","status":"NOT_YET_RECRUITING","sponsor":"Tata Memorial Centre","startDate":"2021-12-01","conditions":"Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8, Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8","enrollment":498}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"Cisplatin based chemotherpay","genericName":"Cisplatin based chemotherpay","companyName":"Tata Memorial Centre","companyId":"tata-memorial-centre","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Cisplatin works by crosslinking DNA, thereby inhibiting DNA replication and transcription. Used for Metastatic non-small cell lung cancer, Testicular cancer, Ovarian cancer.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}